Stephen Lockhart

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 2

Top Topics

Induced Pluripotent Stem Cells

Inflammatory Response

Top Venues

The Journal of experimental medicine

Nature communications

Pfizer

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Jan 02 2017

United Kingdom

Vice President, Europe and Asia Pacific :: Vaccine Clinical R&D

Sanofi Pasteur MSD Ltd Aug 23 2013 - Dec 31 2016

France

Vice President :: Development

Publications

Miwa Haranaka, James Baber, Yoichiro Ogama, Masako Yamaji, Masakazu Aizawa, Osamu Kogawara, Ingrid L Scully, Eleni Lagkadinou, Özlem Tureci, Uğur Şahin, Philip R Dormitzer, William C Gruber, Stephen Lockhart
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults. Nature communications 12 (1) (2021)
Christoph J Blohmke, Thomas C Darton, Claire Jones, Nicolás M Suárez, Claire S Waddington, Brian Angus, Liqing Zhou, Jennifer Hill, Simon Clare, Leanne Kane, Subhankar Mukhopadhyay, Fernanda Schreiber, María A Duque-Correa, James C Wright, Theodoros I Roumeliotis, Lu Yu, Jyoti Sharma Choudhary, Asuncion Mejias, Octavio Ramilo, Milensu Shanyinde, Marcelo B Sztein, Robert A Kingsley, Stephen Lockhart, Myron M Levine, David John Lynn, Gordon Dougan, Andrew J Pollard
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever. The Journal of experimental medicine 213 (6) (2016)